Research article
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
-
* Corresponding author: Jose A Lopez-Guerrero jalopez@fivo.org
- † Equal contributors
1 Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain
2 Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain
3 Department of Medical Oncology, Hospital Arnau de Villanova, Lleida, Spain
4 Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain
5 Department of Pathology, University of Valencia, Spain
6 Department of Radiology, Fundación Instituto Valenciano de Oncología, Valencia, Spain
7 Department of Surgery, Fundación Instituto Valenciano de Oncología, Valencia, Spain
BMC Cancer 2010, 10:36 doi:10.1186/1471-2407-10-36
Published: 9 February 2010Additional files
Additional file 1:
Table S1. Association of clinical, pathological and genotypic parameters with progression free survival (PFS). This table shows the associations of the clinicopathological and genetic parameters with PFS that have not been statistically significant.
Format: DOC Size: 38KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Table S2. Association of clinical, histopathological and genotypic parameters with progression free survival (PFS) according to surgery status. This table shows the associations of the clinicopathological and genetic parameters with PFS that have not been statistically significant according to surgery status.
Format: DOC Size: 55KB Download file
This file can be viewed with: Microsoft Word Viewer